Thyrocare Technologies Ltd reports Q2FY27 revenue of ₹270.8 crore, up 25.1% YoY
- EBITDA rose 24.9% YoY to ₹89.3 crore; EBITDA margin was 33.0%.
- PAT before exceptional items increased 25.7% YoY to ₹60.2 crore.
- Reported PAT was ₹15.2 crore after a one-time, non-cash ₹45 crore impairment tied to the proposed sale of the NHL business.